| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embolization, Therapeutic | 21 | 2023 | 238 | 5.970 |
Why?
|
| Radiography, Interventional | 27 | 2020 | 150 | 4.260 |
Why?
|
| Radiology, Interventional | 14 | 2022 | 68 | 3.840 |
Why?
|
| Vena Cava Filters | 16 | 2022 | 96 | 3.370 |
Why?
|
| Arteriovenous Fistula | 6 | 2023 | 52 | 3.280 |
Why?
|
| Catheterization, Central Venous | 21 | 2015 | 116 | 2.960 |
Why?
|
| Catheterization | 19 | 2023 | 232 | 2.900 |
Why?
|
| Gastrostomy | 9 | 2023 | 69 | 2.900 |
Why?
|
| Renal Dialysis | 25 | 2020 | 355 | 2.880 |
Why?
|
| Catheters, Indwelling | 23 | 2014 | 110 | 2.680 |
Why?
|
| Graft Occlusion, Vascular | 16 | 2020 | 99 | 2.670 |
Why?
|
| Arteriovenous Malformations | 3 | 2023 | 41 | 2.580 |
Why?
|
| Pulmonary Veins | 3 | 2023 | 72 | 2.520 |
Why?
|
| Pulmonary Embolism | 13 | 2022 | 222 | 2.490 |
Why?
|
| Gastrointestinal Hemorrhage | 13 | 2021 | 229 | 2.280 |
Why?
|
| Vena Cava, Inferior | 13 | 2022 | 143 | 2.070 |
Why?
|
| Venous Thrombosis | 11 | 2021 | 243 | 1.850 |
Why?
|
| Carcinoma, Hepatocellular | 7 | 2022 | 384 | 1.750 |
Why?
|
| Liability, Legal | 3 | 2022 | 32 | 1.720 |
Why?
|
| Device Removal | 13 | 2022 | 161 | 1.660 |
Why?
|
| Arteriovenous Shunt, Surgical | 13 | 2020 | 71 | 1.630 |
Why?
|
| Stents | 19 | 2014 | 377 | 1.590 |
Why?
|
| Malpractice | 4 | 2022 | 57 | 1.590 |
Why?
|
| Liver Neoplasms | 8 | 2022 | 736 | 1.580 |
Why?
|
| Angiography | 9 | 2022 | 208 | 1.430 |
Why?
|
| Catheters | 4 | 2023 | 74 | 1.300 |
Why?
|
| Humans | 155 | 2023 | 86643 | 1.280 |
Why?
|
| Angioplasty, Balloon | 12 | 2006 | 95 | 1.270 |
Why?
|
| Postoperative Complications | 15 | 2020 | 2207 | 1.250 |
Why?
|
| Chemoembolization, Therapeutic | 3 | 2020 | 36 | 1.230 |
Why?
|
| Portal Vein | 9 | 2013 | 120 | 1.160 |
Why?
|
| Endoleak | 3 | 2017 | 35 | 1.120 |
Why?
|
| Catheterization, Peripheral | 6 | 2021 | 58 | 1.020 |
Why?
|
| Brachiocephalic Veins | 6 | 2020 | 33 | 1.000 |
Why?
|
| Treatment Outcome | 36 | 2023 | 7993 | 0.990 |
Why?
|
| Jugular Veins | 12 | 2007 | 69 | 0.970 |
Why?
|
| Retrospective Studies | 44 | 2023 | 8489 | 0.950 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.950 |
Why?
|
| Colonic Diseases | 4 | 2015 | 65 | 0.940 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2023 | 16 | 0.900 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 17 | 0.900 |
Why?
|
| Liver Transplantation | 13 | 2013 | 1268 | 0.900 |
Why?
|
| Surgical Stomas | 1 | 2023 | 22 | 0.890 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2023 | 93 | 0.870 |
Why?
|
| Kidney Failure, Chronic | 7 | 2020 | 509 | 0.840 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 188 | 0.820 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2013 | 228 | 0.820 |
Why?
|
| Male | 80 | 2023 | 40965 | 0.820 |
Why?
|
| Middle Aged | 60 | 2023 | 25028 | 0.810 |
Why?
|
| Aneurysm, False | 2 | 2013 | 54 | 0.810 |
Why?
|
| Female | 78 | 2023 | 44532 | 0.740 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2022 | 2601 | 0.730 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 27 | 0.720 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2017 | 112 | 0.710 |
Why?
|
| Prosthesis Failure | 3 | 2014 | 111 | 0.700 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2009 | 62 | 0.700 |
Why?
|
| Contrast Media | 10 | 2022 | 1078 | 0.690 |
Why?
|
| Subclavian Vein | 5 | 2003 | 13 | 0.690 |
Why?
|
| Radiologists | 1 | 2019 | 46 | 0.680 |
Why?
|
| Aged | 46 | 2021 | 18415 | 0.670 |
Why?
|
| Phlebography | 8 | 2017 | 66 | 0.630 |
Why?
|
| Vascular Surgical Procedures | 3 | 2022 | 148 | 0.620 |
Why?
|
| Aneurysm | 2 | 2022 | 58 | 0.600 |
Why?
|
| Mesenteric Arteries | 2 | 2015 | 29 | 0.600 |
Why?
|
| Adult | 41 | 2023 | 25648 | 0.590 |
Why?
|
| Radiology | 3 | 2015 | 194 | 0.590 |
Why?
|
| Hemostatics | 3 | 2013 | 56 | 0.580 |
Why?
|
| Pulmonary Artery | 3 | 2023 | 306 | 0.580 |
Why?
|
| Renal Artery | 2 | 2023 | 64 | 0.570 |
Why?
|
| Appendicitis | 4 | 2001 | 62 | 0.570 |
Why?
|
| Thrombolytic Therapy | 7 | 2020 | 220 | 0.560 |
Why?
|
| Diagnostic Imaging | 6 | 2019 | 469 | 0.560 |
Why?
|
| Thrombectomy | 3 | 2020 | 158 | 0.560 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 849 | 0.550 |
Why?
|
| Catheter Ablation | 3 | 2022 | 233 | 0.550 |
Why?
|
| Aortic Aneurysm | 2 | 2013 | 80 | 0.550 |
Why?
|
| Ultrasonography | 7 | 2014 | 695 | 0.550 |
Why?
|
| Angiography, Digital Subtraction | 4 | 2014 | 92 | 0.530 |
Why?
|
| Aged, 80 and over | 20 | 2020 | 6509 | 0.530 |
Why?
|
| Angioplasty | 6 | 2014 | 70 | 0.530 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.520 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.520 |
Why?
|
| Thrombosis | 7 | 2006 | 296 | 0.510 |
Why?
|
| Time Factors | 20 | 2020 | 5210 | 0.510 |
Why?
|
| Constriction, Pathologic | 14 | 2014 | 213 | 0.510 |
Why?
|
| Physicians | 1 | 2022 | 673 | 0.510 |
Why?
|
| Hepatic Artery | 2 | 2013 | 83 | 0.490 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.490 |
Why?
|
| Upper Extremity | 1 | 2014 | 52 | 0.480 |
Why?
|
| Schools, Medical | 1 | 2014 | 123 | 0.470 |
Why?
|
| Salvage Therapy | 1 | 2014 | 233 | 0.460 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 203 | 0.460 |
Why?
|
| Endovascular Procedures | 2 | 2013 | 218 | 0.460 |
Why?
|
| Thrombin | 1 | 2013 | 61 | 0.450 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 39 | 0.450 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 34 | 0.450 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 92 | 0.430 |
Why?
|
| Vascular Diseases | 3 | 2002 | 121 | 0.430 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 59 | 0.410 |
Why?
|
| Hospitals, University | 1 | 2012 | 194 | 0.400 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 131 | 0.390 |
Why?
|
| Hospital Costs | 1 | 2012 | 105 | 0.390 |
Why?
|
| Radiography | 9 | 2013 | 813 | 0.390 |
Why?
|
| Cholecystectomy | 2 | 2008 | 18 | 0.380 |
Why?
|
| Evidence-Based Medicine | 3 | 2012 | 429 | 0.380 |
Why?
|
| Adolescent | 22 | 2020 | 8981 | 0.380 |
Why?
|
| Veins | 6 | 2006 | 94 | 0.380 |
Why?
|
| Thorax | 3 | 2023 | 75 | 0.380 |
Why?
|
| Radiography, Thoracic | 2 | 2011 | 320 | 0.380 |
Why?
|
| Anticoagulants | 5 | 2020 | 408 | 0.370 |
Why?
|
| Vascular Patency | 10 | 2013 | 126 | 0.370 |
Why?
|
| Rupture | 5 | 2023 | 63 | 0.360 |
Why?
|
| Prosthesis Design | 5 | 2019 | 278 | 0.360 |
Why?
|
| Hand Injuries | 1 | 2009 | 17 | 0.350 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2009 | 18 | 0.350 |
Why?
|
| Students, Medical | 1 | 2014 | 384 | 0.350 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2017 | 208 | 0.350 |
Why?
|
| Occupational Diseases | 1 | 2009 | 55 | 0.340 |
Why?
|
| Follow-Up Studies | 16 | 2017 | 3640 | 0.340 |
Why?
|
| Hematoma | 3 | 2023 | 104 | 0.340 |
Why?
|
| Clinical Competence | 1 | 2014 | 751 | 0.340 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 1991 | 0.330 |
Why?
|
| Common Bile Duct | 1 | 2008 | 19 | 0.330 |
Why?
|
| Choledocholithiasis | 1 | 2008 | 12 | 0.330 |
Why?
|
| Vena Cava, Superior | 4 | 2023 | 59 | 0.320 |
Why?
|
| Diagnosis, Differential | 7 | 2012 | 1565 | 0.320 |
Why?
|
| Postoperative Hemorrhage | 1 | 2008 | 46 | 0.310 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 731 | 0.310 |
Why?
|
| Nephrectomy | 1 | 2010 | 294 | 0.310 |
Why?
|
| Lower Gastrointestinal Tract | 2 | 2004 | 8 | 0.310 |
Why?
|
| Brachial Artery | 2 | 2020 | 36 | 0.310 |
Why?
|
| Risk Factors | 12 | 2021 | 5417 | 0.300 |
Why?
|
| Pipecolic Acids | 1 | 2006 | 14 | 0.290 |
Why?
|
| Equipment Failure | 6 | 2011 | 119 | 0.290 |
Why?
|
| Young Adult | 9 | 2020 | 5976 | 0.290 |
Why?
|
| Fluoroscopy | 8 | 2020 | 119 | 0.280 |
Why?
|
| Drainage | 4 | 2009 | 157 | 0.270 |
Why?
|
| Iliac Vein | 2 | 2011 | 30 | 0.270 |
Why?
|
| Fistula | 2 | 2021 | 42 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 2360 | 0.260 |
Why?
|
| Central Venous Catheters | 2 | 2015 | 23 | 0.250 |
Why?
|
| Nephrostomy, Percutaneous | 2 | 2004 | 31 | 0.250 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 621 | 0.250 |
Why?
|
| Medicare | 3 | 2021 | 410 | 0.240 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2022 | 70 | 0.240 |
Why?
|
| Jejunostomy | 1 | 2003 | 14 | 0.240 |
Why?
|
| Risk Assessment | 6 | 2020 | 2261 | 0.240 |
Why?
|
| Recurrence | 5 | 2020 | 1139 | 0.240 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2011 | 40 | 0.230 |
Why?
|
| Femoral Vein | 3 | 2005 | 35 | 0.230 |
Why?
|
| Dialysis | 1 | 2003 | 24 | 0.230 |
Why?
|
| Equipment Design | 4 | 2015 | 406 | 0.230 |
Why?
|
| Vascular Fistula | 1 | 2003 | 12 | 0.230 |
Why?
|
| Radiation Dosage | 2 | 2020 | 227 | 0.220 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2002 | 15 | 0.220 |
Why?
|
| Workload | 2 | 2020 | 128 | 0.220 |
Why?
|
| Venous Pressure | 1 | 2002 | 11 | 0.220 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 47 | 0.220 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2002 | 5 | 0.210 |
Why?
|
| Chicago | 5 | 2019 | 1379 | 0.210 |
Why?
|
| Referral and Consultation | 1 | 2004 | 328 | 0.200 |
Why?
|
| Appendix | 1 | 2001 | 31 | 0.200 |
Why?
|
| Arteries | 1 | 2022 | 176 | 0.200 |
Why?
|
| Leg | 1 | 2002 | 137 | 0.200 |
Why?
|
| Acute Disease | 3 | 2015 | 826 | 0.200 |
Why?
|
| Bile Duct Neoplasms | 1 | 2022 | 79 | 0.200 |
Why?
|
| Acetylcysteine | 1 | 2001 | 69 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2020 | 268 | 0.190 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1052 | 0.190 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.190 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 38 | 0.190 |
Why?
|
| Hospital Charges | 1 | 2020 | 29 | 0.190 |
Why?
|
| Platelet Count | 1 | 2020 | 92 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2022 | 238 | 0.190 |
Why?
|
| Ultrasonography, Interventional | 3 | 2009 | 121 | 0.190 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2020 | 64 | 0.190 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 53 | 0.180 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 76 | 0.180 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 1999 | 17 | 0.180 |
Why?
|
| Ligaments | 1 | 2000 | 32 | 0.180 |
Why?
|
| Celiac Artery | 1 | 2000 | 25 | 0.180 |
Why?
|
| Diaphragm | 1 | 2000 | 50 | 0.180 |
Why?
|
| Diverticulum | 1 | 2000 | 44 | 0.180 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 180 | 0.180 |
Why?
|
| United States | 7 | 2021 | 6672 | 0.180 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 63 | 0.180 |
Why?
|
| Saphenous Vein | 1 | 1999 | 61 | 0.170 |
Why?
|
| Arm | 1 | 1999 | 91 | 0.170 |
Why?
|
| Infant | 8 | 2013 | 3046 | 0.170 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2000 | 107 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2705 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 582 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2003 | 3362 | 0.170 |
Why?
|
| Hemodynamics | 1 | 2002 | 710 | 0.170 |
Why?
|
| Treatment Refusal | 1 | 1998 | 60 | 0.160 |
Why?
|
| Child, Preschool | 12 | 2006 | 3612 | 0.160 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 98 | 0.160 |
Why?
|
| Blood Flow Velocity | 2 | 2016 | 197 | 0.160 |
Why?
|
| Colon | 1 | 2001 | 496 | 0.160 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 125 | 0.160 |
Why?
|
| Anastomosis, Surgical | 5 | 2005 | 267 | 0.160 |
Why?
|
| Colonoscopy | 1 | 2000 | 264 | 0.160 |
Why?
|
| Suture Techniques | 2 | 2014 | 135 | 0.160 |
Why?
|
| Heparin Antagonists | 1 | 1997 | 3 | 0.160 |
Why?
|
| Protamines | 1 | 1997 | 8 | 0.160 |
Why?
|
| Hepatic Veins | 2 | 2011 | 27 | 0.160 |
Why?
|
| Drug Hypersensitivity | 1 | 1997 | 37 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 1998 | 141 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 1673 | 0.150 |
Why?
|
| Neck | 1 | 1998 | 100 | 0.150 |
Why?
|
| Catheter-Related Infections | 2 | 2014 | 23 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2001 | 418 | 0.150 |
Why?
|
| Iliac Artery | 2 | 2011 | 35 | 0.150 |
Why?
|
| Gadolinium DTPA | 1 | 1998 | 261 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 4 | 2012 | 454 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Child | 13 | 2006 | 6927 | 0.150 |
Why?
|
| Incidence | 3 | 2015 | 1577 | 0.140 |
Why?
|
| Brachiocephalic Trunk | 1 | 2016 | 14 | 0.140 |
Why?
|
| Stomach | 2 | 2011 | 108 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1998 | 262 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 413 | 0.140 |
Why?
|
| Prospective Studies | 7 | 2020 | 4213 | 0.130 |
Why?
|
| Meningitis, Bacterial | 1 | 1995 | 13 | 0.130 |
Why?
|
| Sutures | 2 | 2014 | 52 | 0.130 |
Why?
|
| Actinomycosis | 1 | 1995 | 12 | 0.130 |
Why?
|
| Computer Simulation | 3 | 2020 | 1078 | 0.130 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 5 | 0.130 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2014 | 2 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2015 | 154 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 1036 | 0.120 |
Why?
|
| Punctures | 3 | 2005 | 29 | 0.120 |
Why?
|
| Colectomy | 1 | 2015 | 167 | 0.120 |
Why?
|
| Reoperation | 2 | 2014 | 597 | 0.120 |
Why?
|
| Cholangiography | 3 | 2005 | 41 | 0.120 |
Why?
|
| Sampling Studies | 1 | 2013 | 70 | 0.110 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 117 | 0.110 |
Why?
|
| Dilatation | 2 | 2006 | 48 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2014 | 182 | 0.110 |
Why?
|
| Feasibility Studies | 4 | 2011 | 751 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2013 | 285 | 0.110 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2004 | 19 | 0.110 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 429 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 567 | 0.110 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 51 | 0.100 |
Why?
|
| Decision Trees | 1 | 2012 | 63 | 0.100 |
Why?
|
| Thoracic Diseases | 1 | 2012 | 25 | 0.100 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2011 | 34 | 0.100 |
Why?
|
| Cost Savings | 1 | 2012 | 66 | 0.100 |
Why?
|
| Models, Economic | 1 | 2012 | 60 | 0.100 |
Why?
|
| Hawaii | 4 | 1998 | 26 | 0.100 |
Why?
|
| Cholecystography | 1 | 2011 | 6 | 0.100 |
Why?
|
| Uterine Artery Embolization | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cholecystostomy | 1 | 2011 | 3 | 0.100 |
Why?
|
| Regional Blood Flow | 2 | 2020 | 197 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 185 | 0.100 |
Why?
|
| Survival Rate | 1 | 2015 | 1863 | 0.100 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.100 |
Why?
|
| Urokinase-Type Plasminogen Activator | 3 | 2005 | 47 | 0.100 |
Why?
|
| Needles | 3 | 2001 | 35 | 0.100 |
Why?
|
| Aortography | 1 | 2011 | 63 | 0.100 |
Why?
|
| Yttrium Radioisotopes | 2 | 2021 | 46 | 0.100 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 43 | 0.100 |
Why?
|
| Duodenum | 1 | 2011 | 100 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 160 | 0.090 |
Why?
|
| Renal Veins | 2 | 2017 | 28 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 87 | 0.090 |
Why?
|
| Body Fluids | 1 | 2009 | 36 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2012 | 328 | 0.090 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2001 | 31 | 0.090 |
Why?
|
| Collateral Circulation | 2 | 2001 | 35 | 0.090 |
Why?
|
| Retroperitoneal Space | 1 | 2009 | 38 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 239 | 0.090 |
Why?
|
| Enteral Nutrition | 2 | 2021 | 102 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2009 | 63 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2012 | 359 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 168 | 0.080 |
Why?
|
| Syndrome | 1 | 2009 | 446 | 0.080 |
Why?
|
| Polytetrafluoroethylene | 2 | 1999 | 74 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 153 | 0.080 |
Why?
|
| Travel | 1 | 1988 | 68 | 0.080 |
Why?
|
| Illinois | 2 | 2014 | 462 | 0.080 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 194 | 0.080 |
Why?
|
| Neoplasms | 2 | 2002 | 2898 | 0.080 |
Why?
|
| Scabies | 1 | 1987 | 1 | 0.080 |
Why?
|
| Heart | 1 | 2011 | 539 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 225 | 0.080 |
Why?
|
| Stress, Mechanical | 2 | 2020 | 248 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2011 | 191 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2011 | 227 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1801 | 0.070 |
Why?
|
| Budd-Chiari Syndrome | 1 | 2006 | 9 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2010 | 563 | 0.070 |
Why?
|
| Hemofiltration | 1 | 2006 | 11 | 0.070 |
Why?
|
| Skin Diseases | 1 | 1988 | 166 | 0.070 |
Why?
|
| Life Tables | 3 | 2005 | 48 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 2 | 1997 | 80 | 0.070 |
Why?
|
| Herpes Zoster | 1 | 1987 | 78 | 0.070 |
Why?
|
| Arginine | 1 | 2006 | 136 | 0.070 |
Why?
|
| Splenorenal Shunt, Surgical | 1 | 2005 | 3 | 0.070 |
Why?
|
| Extremities | 1 | 2006 | 167 | 0.070 |
Why?
|
| Biliary Tract Diseases | 1 | 2005 | 34 | 0.060 |
Why?
|
| Retreatment | 2 | 2002 | 107 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2006 | 300 | 0.060 |
Why?
|
| Duodenal Diseases | 1 | 2004 | 24 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 297 | 0.060 |
Why?
|
| Hydronephrosis | 1 | 2004 | 31 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 1019 | 0.060 |
Why?
|
| Urinary Catheterization | 1 | 2004 | 35 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1313 | 0.060 |
Why?
|
| Phlebotomy | 2 | 2001 | 21 | 0.060 |
Why?
|
| Technetium | 1 | 2003 | 29 | 0.060 |
Why?
|
| Iatrogenic Disease | 2 | 2002 | 69 | 0.060 |
Why?
|
| Ureteral Obstruction | 1 | 2004 | 67 | 0.060 |
Why?
|
| Pneumothorax | 2 | 2000 | 52 | 0.060 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2003 | 10 | 0.060 |
Why?
|
| Splenic Artery | 1 | 2022 | 11 | 0.060 |
Why?
|
| Boston | 1 | 2022 | 33 | 0.050 |
Why?
|
| Vasopressins | 1 | 2002 | 49 | 0.050 |
Why?
|
| New York | 1 | 2022 | 69 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2003 | 146 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2002 | 59 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 255 | 0.050 |
Why?
|
| Intubation | 2 | 1999 | 21 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 34 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 860 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 113 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 1999 | 244 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2001 | 25 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2021 | 84 | 0.050 |
Why?
|
| Tourniquets | 1 | 2000 | 7 | 0.050 |
Why?
|
| Bile | 1 | 2001 | 57 | 0.050 |
Why?
|
| Administration, Rectal | 1 | 2000 | 12 | 0.050 |
Why?
|
| Hemostasis, Surgical | 1 | 2000 | 26 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2002 | 185 | 0.050 |
Why?
|
| Physician's Role | 1 | 2002 | 179 | 0.050 |
Why?
|
| Neointima | 1 | 2020 | 13 | 0.050 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 15 | 0.050 |
Why?
|
| Age Factors | 3 | 2014 | 1851 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 58 | 0.050 |
Why?
|
| Heparin | 2 | 1999 | 175 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2020 | 91 | 0.050 |
Why?
|
| Workflow | 1 | 2020 | 77 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2020 | 148 | 0.050 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2000 | 18 | 0.050 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 66 | 0.050 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1999 | 41 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2020 | 235 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2003 | 1538 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 37 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 70 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 24 | 0.040 |
Why?
|
| Metformin | 1 | 2001 | 128 | 0.040 |
Why?
|
| Thigh | 1 | 1999 | 38 | 0.040 |
Why?
|
| Plasminogen Activators | 1 | 1999 | 11 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 2262 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 149 | 0.040 |
Why?
|
| Diatrizoate Meglumine | 1 | 1998 | 24 | 0.040 |
Why?
|
| Jejunum | 1 | 1999 | 79 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2019 | 114 | 0.040 |
Why?
|
| Hemostatic Techniques | 1 | 1998 | 14 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 1998 | 32 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2022 | 814 | 0.040 |
Why?
|
| Suction | 1 | 1998 | 35 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 134 | 0.040 |
Why?
|
| Insulin, Isophane | 1 | 1997 | 2 | 0.040 |
Why?
|
| Urinary Diversion | 1 | 1998 | 42 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1997 | 15 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 1998 | 127 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 1997 | 64 | 0.040 |
Why?
|
| Drug Interactions | 1 | 1997 | 248 | 0.040 |
Why?
|
| Ureter | 1 | 1998 | 92 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 916 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 1998 | 270 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 1997 | 181 | 0.040 |
Why?
|
| Sex Factors | 2 | 2014 | 1054 | 0.030 |
Why?
|
| Esophageal and Gastric Varices | 2 | 2006 | 33 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1998 | 306 | 0.030 |
Why?
|
| Diabetic Nephropathies | 2 | 2009 | 248 | 0.030 |
Why?
|
| Methods | 1 | 1995 | 152 | 0.030 |
Why?
|
| Cavernous Sinus | 1 | 1995 | 15 | 0.030 |
Why?
|
| Brain Edema | 1 | 1995 | 50 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 1997 | 378 | 0.030 |
Why?
|
| Blood Viscosity | 1 | 2014 | 16 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 1961 | 0.030 |
Why?
|
| Patient-Specific Modeling | 1 | 2014 | 19 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 173 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 204 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 364 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2001 | 1004 | 0.030 |
Why?
|
| Kidney | 1 | 1998 | 1241 | 0.030 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 21 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2012 | 80 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 999 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2006 | 2379 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2011 | 46 | 0.020 |
Why?
|
| Contraindications | 1 | 2011 | 72 | 0.020 |
Why?
|
| Ultrasonic Therapy | 1 | 2011 | 32 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 943 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2011 | 146 | 0.020 |
Why?
|
| APACHE | 1 | 2009 | 21 | 0.020 |
Why?
|
| Uterus | 1 | 2011 | 215 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1143 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 421 | 0.020 |
Why?
|
| Alloys | 1 | 2007 | 10 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Outpatients | 1 | 2008 | 94 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 770 | 0.020 |
Why?
|
| Equipment Safety | 1 | 2007 | 31 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 752 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 58 | 0.020 |
Why?
|
| Bacteremia | 1 | 2007 | 99 | 0.020 |
Why?
|
| Femur | 1 | 2005 | 116 | 0.020 |
Why?
|
| Brain | 1 | 1995 | 2216 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 255 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2005 | 162 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2011 | 754 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 42 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 594 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 220 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 185 | 0.010 |
Why?
|
| Probability | 1 | 2003 | 355 | 0.010 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2002 | 50 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 746 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 674 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 602 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 478 | 0.010 |
Why?
|
| Living Donors | 1 | 2002 | 339 | 0.010 |
Why?
|
| Registries | 1 | 2003 | 702 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 884 | 0.010 |
Why?
|
| Ureteral Diseases | 1 | 1998 | 14 | 0.010 |
Why?
|
| Intestinal Fistula | 1 | 1998 | 30 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 1805 | 0.010 |
Why?
|
| Kidney Pelvis | 1 | 1998 | 50 | 0.010 |
Why?
|
| Cause of Death | 1 | 1999 | 277 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1998 | 160 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1998 | 153 | 0.010 |
Why?
|
| Cystectomy | 1 | 1998 | 102 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 1999 | 462 | 0.010 |
Why?
|
| Ischemia | 1 | 1998 | 243 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1996 | 463 | 0.010 |
Why?
|